![](/img/cover-not-exists.png)
MP-19.10: Does intermittent low weekly doses of docetaxel-estramustine have an impact on treatment outcome in hormone refractory prostate cancer?
H. El-Shawaf, K.M. Galal, A.-M.M. MouradVolume:
68
Year:
2006
Language:
english
DOI:
10.1016/j.urology.2006.08.570
File:
PDF, 65 KB
english, 2006